References
Torricelli P, Fini M, Filardo G et al (2011) Regenerative medicine for the treatment of musculoskeletal overuse injuries in competition horses. Int Orthop. doi:10.1007/s00264-011-1237-3
Kon E, Filardo G, Delcogliano M et al (2010) Platelet autologous growth factors decrease the osteochondral regeneration capability of a collagen-hydroxyapatite scaffold in a sheep model. BMC Musculoskelet Disord 11:220
Weibrich G, Hansen T, Kleis W, Buch R, Hitzler WE (2004) Effect of platelet concentration in platelet-rich plasma on peri-implant bone regeneration. Bone 34:665–671
Tschon M, Fini M, Giardino R et al (2011) Lights and shadows concerning platelet products for musculoskeletal regeneration. Front Biosci (Elite Ed) 3:96–107
Wu Q, Shao H, Darwin ED et al (2009) Extracellular calcium increase CXCR4 expression on bone marrow-derived cells and enhances pro-angiogenesis therapy. J Cell Mol Med 9B:3764–3773
Martino NA, Lange-Consiglio A, Cremonesi F et al (2011) Functional expression of the extracellular calcium sensing receptor (CaSR) in equine umbilical cord matrix size-sieved stem cells. PLoS One 6(3):e17714
Tao R, Lau CP, Tse HF, Li GR (2008) Regulation of cell proliferation by intermediate-conductance Ca2+-activated potassium and volume-sensitive chloride channels in mouse mesenchymal stem cells. Am J Physiol Cell Physiol 295:C1409–C1416
Reinholz GG, Getz B, Pederson L et al (2000) Bisphosphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblasts. Cancer Res 60:6001–6007
Del Bue M, Riccò S, Ramoni R, Conti V, Gnudi G, Grolli S (2008) Equine adipose-tissue derived mesenchymal stem cells and platelet concentrates: their association in vitro and in vivo. Vet Res Commun 32(Suppl 1):S51–S55
McCarrel T, Fortier L (2009) Temporal growth factor release from platelet-rich plasma, trehalose lyophilized platelets, and bone marrow aspirate and their effect on tendon and ligament gene expression. J Orthop Res 27(8):1033–1042
Smith RKW, Korda M, Blunn GW et al (2003) Isolation and implantation of autologous equine mesenchymal stem cells from bone marrow into the superficial digital flexor tendon as a potential novel treatment. Equine Vet 35:99–102
Koch TG, Berg LC, Betts DH (2009) Current and future regenerative medicine—principles, concepts, and therapeutic use of stem cell therapy and tissue engineering in equine medicine. Can Vet J 50(2):155–165
Taylor SE, Smith RK, Clegg PD (2007) Mesenchymal stem cell therapy in equine musculoskeletal disease: scientific fact or clinical fiction? Equine Vet J 39(2):172–180
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Torricelli, P., Filardo, G., Kon, E. et al. Reply to comments of Carmona et al. to the article: Regenerative medicine for the treatment of musculoskeletal overuse injuries in competition horses. International Orthopaedics (SICOT) 35, 1747–1748 (2011). https://doi.org/10.1007/s00264-011-1312-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00264-011-1312-9